Welcome to our dedicated page for VSee Health news (Ticker: VSEE), a resource for investors and traders seeking the latest updates and insights on VSee Health stock.
VSee Health, Inc. (NASDAQ: VSEE) is a telehealth technology and services company whose news flow centers on AI-powered virtual care, digital health infrastructure, and capital markets developments. As a health information services provider, VSee regularly issues updates on its telehealth platform, AI initiatives, hospital partnerships, and regulatory milestones, giving investors and healthcare stakeholders insight into how the business is evolving.
Company press releases highlight product and solution launches, such as the AI-enhanced Rural Health Transformation Solution designed for rural hospitals, and initiatives that apply VSee’s configurable digital health infrastructure to specialty access, clinical workflows, and financial performance. News items also cover collaborations with health systems on tele-urgent care, teleradiology, telenursing, and high-acuity virtual care programs, as well as international projects in regions like Southeast Asia where VSee’s platform supports maternal health, primary care, and tuberculosis screening efforts.
VSEE news frequently addresses AI and security credentials, including references to FedRAMP High Authority to Operate from the U.S. Department of Health and Human Services and FedRAMP Moderate authorization related to federal telehealth deployments. These updates help readers understand how VSee positions its telehealth and AI infrastructure for hospital systems, health networks, employers, and government partners.
In addition, VSee’s news feed includes financial and corporate disclosures that complement its SEC filings, such as announcements of private placements, equity line arrangements, convertible notes, and Nasdaq listing compliance updates. Readers following VSEE news can track how the company’s technology initiatives, service contracts, and financing activities intersect, and can return to this page to review new releases as they are published.
VSEE Health (NASDAQ:VSEE) announced a strategic managed services partnership with GoMyRx, an affiliate of GoMyDocs, to expand integrated digital healthcare delivery and telehealth-enabled medication fulfillment nationwide.
Under the agreement, GoMyRx will act as VSEE Health's primary operational integration partner for prescription workflow coordination, medication fulfillment, and direct-to-patient delivery, leveraging GoMyRx's national platform with annual gross transaction volume exceeding $10 million and GoMyDocs' compounding and logistics network. The integrated platform links VSEE Health's secure video visits, AI-assisted clinical workflows, remote patient monitoring, and EHR integrations with fulfillment operations to support scalable virtual care and medication delivery.
VSee Health (Nasdaq:VSEE) will host a live webinar, "The On‑Demand ICU: Sustainable Rural Healthcare", on February 4, 2026 at 11:00 AM PT / 2:00 ET. The session will discuss tele‑ICU and mobile ICU models for rural hospitals, staffing relief, clinician sustainability, and financial recovery.
Speakers include Docbox CEO Bobby Shah and VSee CEO Milton Chen. Topics highlight capturing up to $1M in recovered revenue over five years, automated vitals‑to‑EHR workflows, bi‑directional video, real‑time access to labs/PACS, and data/AI infrastructure for scalable remote ICU care.
VSee Health (Nasdaq:VSEE) announced a strategic partnership with DocBox to build the first AI-native, augmented‑intelligence Virtual ICU operating system for hospitals worldwide.
The joint platform embeds live bedside device data into VSee telehealth workflows to enable 24/7 remote ICU coverage, automated billing capture into the EHR, AI copilots on real physiology, and support for rural hospital programs.
VSee (Nasdaq:VSEE) launched an AI‑driven Rural Health Transformation Solution on January 12, 2026 to help rural hospitals expand specialty access, reduce avoidable transfers, and improve financial sustainability.
The modular platform combines Uber‑like specialist routing, AI clinical assistants, and predictive early‑warning systems. VSee modeled a representative 70‑bed hospital and estimated $6.6M annual revenue leakage from transfers and up to $5.3M potential annual retention; an additional $300k–$1.6M annual opportunity from reduced patient bypass was noted.
The solution targets alignment with the CMS Rural Health Transformation Program ($10B/year for five years) and will be discussed at the J.P. Morgan Healthcare Conference Jan 12–15, 2026.
VSee Health (NASDAQ:VSEE) announced it is postponing its 2025 Annual Meeting of Stockholders from December 15, 2025 at 2:30 p.m. ET to December 30, 2025 at 2:30 p.m. ET because it does not anticipate a quorum.
The meeting will be held via live webcast at https://www.cstproxy.com/vseehealth/2025. The record date remains November 20, 2025. Stockholders who already voted do not need to act; those who have not voted are encouraged to vote by December 29, 2025 at 11:59 p.m. ET. No proposal changes were made.
VSee Health (Nasdaq:VSEE, VSEEW) announced it has regained compliance with Nasdaq Listing Rule 5550(b)(1) after its stockholders' equity rose to approximately $9.5 million pro forma as of December 1, 2025. The company attributes the increase to: full conversion of multiple convertible notes into common stock; cash exercise and exchange of certain public warrants; and a $6.0 million private placement (or pre-funded warrants) with accompanying warrants completed on November 25, 2025. A pro forma balance sheet was filed on Form 8-K/A on December 11, 2025. The company said the transactions reduced debt and derivative liabilities and provided additional working capital for its telehealth and digital health operations.
VSee Health (Nasdaq:VSEE) announced a webinar on December 4, 2025, with Novant Health Urgent Care to share a blueprint for building scalable, profitable tele‑urgent programs.
The session will highlight a client case where VSee helped Novant Health Urgent Care streamline clinic operations, customize digital intake forms, and execute a full brand refresh across web and mobile. Topics include boosting telehealth ROI via optimized volumes, billing and staffing, implementing scalable technology architectures, and leveraging AI/automation to improve care delivery in rural and resource‑constrained areas. The webinar is free to attend and targets health systems expanding virtual urgent care.
VSee Health (NASDAQ:VSEE) announced a private placement with a single institutional investor to raise approximately $6.0 million in gross proceeds. The financing consists of 9,836,065 shares (or equivalents) and warrants to purchase up to 19,672,130 shares at a combined effective price of $0.61 per share.
The warrants carry a $0.61 exercise price, are exercisable following shareholder approval, and expire five years from initial exercise. Closing is expected on or about December 1, 2025. The company plans to use net proceeds for working capital and general corporate purposes and engaged A.G.P./Alliance Global Partners as sole placement agent.
The company will file a resale registration statement within 20 calendar days of closing and aims to have it declared effective within 60 days.
VSee Health (NASDAQ:VSEE) announced progress executing contracts through its iDoc telemedicine platform on November 25, 2025. Key execution items: two new hospitals are live and are conservatively projected to generate $500,000 in annual revenue; 21 of 34 hospitals in its Health network are activated with 7 more slated for Q1 2026; four new teleradiology hospitals were activated recently; and one Large Regional Leading Hospital partnership targets a Jan/Feb 2026 launch for virtual urgent care and behavioral health. VSee said it has submitted proposals for two new hospital contracts with a combined potential value of $3 million if awarded. The company emphasized scaling teleradiology, telenursing, and telehealth services to convert contracted deals into recurring revenue.
VSee Health (Nasdaq:VSEE) named Dr. Milton Chen as chairman of the board on November 20, 2025.
Dr. Chen cofounded VSee, wrote the first VSee software as a Stanford PhD student, and has defined the company's no-code, low-code AI infrastructure strategy. The announcement says VSee's building blocks help connect AI modules to hospitals by providing EMR integration, event queueing, and security.
Management highlights include Dr. Chen's 15+ years of AI telehealth product development and board leadership, and prior deployments of VSee for public figures cited as examples of company use.
FAQ
What is the current stock price of VSee Health (VSEE)?
What is the market cap of VSee Health (VSEE)?
